CLINICAL IMPACT OF IMMUNOSUPPRESSIVE COMBINATION THERAPY IN MPO-ANCA–ASSOCIATED RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS: A RETROSPECTIVE COMPARISON WITH STEROID MONOTHERAPY

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 

 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

  Back
E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/febcb3842f04c9d5aa93f8524a3579f1.pdf
CLINICAL IMPACT OF IMMUNOSUPPRESSIVE COMBINATION THERAPY IN MPO-ANCA–ASSOCIATED RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS: A RETROSPECTIVE COMPARISON WITH STEROID MONOTHERAPY

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Kentaro
Watanabe
Kentaro Watanabe babibubeballpen@gmail.com Kurashiki Central Hospital Nephrology Kurashiki Japan *
Akiyuki Zushi az18230@kchnet.or.jp Kurashiki Central Hospital Nephrology Kurashiki Japan -
Toru Mitsuhashi tm18243@kchnet.or.jp Kurashiki Central Hospital Nephrology Kurashiki Japan -
Kyohei Higashi kh17429@kchnet.or.jp Kurashiki Central Hospital Nephrology Kurashiki Japan -
Rina Sanoh rs17863@kchnet.or.jp Kurashiki Central Hospital Nephrology Kurashiki Japan -
Tomoko Konishi tk17465@kchnet.or.jp Kurashiki Central Hospital Nephrology Kurashiki Japan -
Jiaqi Xu kk17458@kchnet.or.jp Kurashiki Central Hospital Nephrology Kurashiki Japan -
Takahiro Kida tk17005@kchnet.or.jp Kurashiki Central Hospital Nephrology Kurashiki Japan -
Misaki Nakamura mn17480@kchnet.or.jp Kurashiki Central Hospital Nephrology Kurashiki Japan -
Motoyasu Kurahashi mk18254@kchnet.or.jp Kurashiki Central Hospital Nephrology Kurashiki Japan -
Mana Nishikawa mn13547@kchnet.or.jp Kurashiki Central Hospital Nephrology Kurashiki Japan -
Motoko Kanzaki mk14727@kchnet.or.jp Kurashiki Central Hospital Nephrology Kurashiki Japan -
Kosuke Fukuoka kf15710@kchnet.or.jp Kurashiki Central Hospital Nephrology Kurashiki Japan -
Kenichiro Asano ka11734@kchnet.or.jp Kurashiki Central Hospital Nephrology Kurashiki Japan -
Noriaki Shimada nshimada@kchnet.or.jp Kurashiki Central Hospital Nephrology Kurashiki Japan -